·5 min read

The 8-week window where most people quit a GLP-1 (and what to do instead)

A coach in Singapore told me the same thing my doctor friend in Bangkok told me: the people who quit tirzepatide almost all quit between week 6 and week 10. The reason isn't the side effects you'd guess. It's the gap between when the discomfort peaks and when the visible results start showing up.

A coach in Singapore who runs weight management groups told me a stat I've been thinking about for weeks. Of the people in her programs who start tirzepatide, about a third quit. Of the people who quit, almost all of them quit between week six and week ten. Not the first month, when the side effects hit hardest. Not month five, when the plateau frustrates people. Week six to week ten.

She has a theory. The first month is dramatic. You feel different. Food noise drops. You're aware of every change. The second month, you're starting to feel like yourself again, but you haven't lost enough weight yet for anyone (including you) to see it in the mirror. The discomfort hasn't fully resolved. The reward hasn't shown up. You're paying a real cost in side effects, lifestyle adjustments, and money, and you're not yet getting visible payoff. So you start asking, quietly: is this worth it?

Her programs have figured out that this window is when intervention matters most. If a patient calls during this window, drop everything and call them back the same day. If they don't call, the coach calls them. The check-in itself, she says, often is the difference between someone who continues and someone who quits.

This matches what my doctor friend in Bangkok sees. She told me the patients who do best on tirzepatide aren't the ones with the cleanest first month. They're the ones who get through week eight without quitting. After week ten, the visible results start to outpace the lingering discomfort, and the math flips.

Three things help most people through that window.

The first is reframing. The first month, you measure your progress in side effects ("I felt nauseous on day three"). Around week six, you need to switch to measuring it in something else. How your clothes fit. Your resting heart rate if you have a watch. The food noise scale (do you still think about food the way you used to?). Some people use weekly photos. Some use waist measurements. Whatever you choose, make it something you can see changing in the window when the scale isn't moving fast enough.

The second is dose discipline. Week six is often when someone is on 5mg or 7.5mg and considering stepping up because "this isn't working fast enough." Don't. The step-up doesn't accelerate weight loss in the next week; it accelerates side effects. The published trial data shows weight loss continues through month four, five, six on the same dose. If you're tolerating 5mg well at week six, staying there for another four weeks is almost always the right call. The people who keep stepping up because they're impatient are the same people who quit at week eight when the side effects get worse.

The third is structural support. Not motivation. Structure. Most people in the quit-window aren't lacking motivation; they're lacking decisions that have already been made. Plan your meals for the week on Sunday. Pre-decide your shot day and time. Schedule your weigh-in. Block 20 minutes of walking on your calendar. Make the small daily decisions before you have to make them, when you're tired and your willpower is depleted.

What surprised me the most when I started paying attention to this window is how rarely it's discussed in marketing copy. Telehealth platforms talk about the first month (here are your common side effects, contact us if you have concerns). They talk about the year-end results (here's your before-and-after). They don't talk about the eight-week window because it's not a moment that sells anything. It's the boring middle. It's where adherence gets won or lost.

If you're in this window right now, here's what I'd actually do: call whoever prescribed your medication and tell them you're considering stopping. Don't sugar-coat it. The honest answer might be "you're past the rough part, give it three more weeks." It might be "let's drop you back to a lower dose." It might be "let's pause and try again in a few months." Any of those is better than ghosting your prescription and going off cold.

If you're a coach or a clinician reading this, the action item is simpler: call your week-eight people. They probably won't call you. The fact that you noticed and reached out is often the thing that changes the trajectory.

The medication does the chemistry. The first eight weeks do the rest.

Share this post
Friday digest

One email a week. Catalog updates, new posts, BKK supply state. No spam, no MLM. What lands in the inbox →

We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.

About the editor

Mira Tanaka is the editor at panya, based in Bangkok. Editor at Panya. Covers peptide therapeutics with a focus on the routing decisions mainstream adults actually face. Corrections, tips, or push-back: editor@panya.health.